Surgeons attending the ASCRS meeting this week can preview Sight Sciences’s new Omni Edge MIGS system. Read more: ow.ly/ffpU50VFQx1 #GlaucomaPhysician #GPnews #OmniEdge #MIGS #Conexiant

If you are in LA, come and check out Glaucoma Day! The best day in glaucoma education has begun!!! ASCRS Manjool Shah

SpyGlass Pharma’s drug-eluting IOL platform showed good visual and pressure-lowering benefits at 18 months. Read more: ow.ly/CPKS50VIPeV #GlaucomaPhysician #GPnews #proceduralpharmaceuticals #SpyGlassPharma #Conexiant

The June issue of Glaucoma Physician is now available at ow.ly/Agbq50W2jLY #GlaucomaPhysician #GPnews #MIGS #InterventionalGlaucoma #Conexiant

A recently published study may help clinicians identify early signs of unilateral or asymmetric glaucoma on OCT. Read more: ow.ly/sYNt50W5yjt #GlaucomaPhysician #Gpnews #OCT #imaging #RNFL #Conexiant

Mike Cymbor, OD, and Parag D. Parekh, MD, explain how a shared-care model can improve outcomes, efficiency, and patient satisfaction. Read more: ow.ly/Zl1B50W6tEn #GlaucomaPhysician #GPnews #comanagement #optometry #Conexiant

In this month’s Surgical Pearls video, Huda Sheheitli, MD, presents a technique for surgical revision of an exposed Baerveldt tube shunt associated with scleral melt. View here: ow.ly/fJj250W6yPB #GlaucomaPhysician #GPnews #SurgicalPearls #Conexiant

In the complex world of surgical reimbursement, patient advocacy begins with documentation, writes Elizabeth Cifers, MBA, MSW, CHC, CPC. Read more: ow.ly/HYnq50W6yAs #GlaucomaPhysician #GPnews #practicemanagement #Conexiant

A recently published study associates intraocular interferon beta with glaucoma risk. Read more: ow.ly/LQZC50W6zui #GlaucomaPhysician #GPnews #riskfactors #Conexiant

Qlaris Bio is developing a fixed-dose combination therapy that combines its investigational drug QLS-111 with latanoprost. Read more: ow.ly/1hUC50W7SP1 #GlaucomaPhysician #GPnews #medicaltherapy #EVP #IOP #Conexiant

Steven R. Sarkkisian Jr, MD, explains how a deliberate and proactive surgical strategy is necessary to achieve optimal outcomes. Read more: ow.ly/27Vq50W6yvh #GlaucomaPhysician #GPnews #interventionalglaucoma #MIGS #Conexiant

This month’s Spotlight column reviews the Voyager DSLT system. Read more: ow.ly/ks4v50W6zee #GlaucomaPhysician #GPnews #laser #Alcon #SLT #Conexiant

Christine Funke, MD, and Deborah Ristvedt, DO, discuss how early therapeutic procedures can change the trajectory of glaucoma care. Read more: ow.ly/KJ3T50W6yEL #GlaucomaPhysician #GPnews #interventionalglaucoma #Conexiant

A European study found that IOP rises with increased physical intensity and drops after exercise, suggesting a dose-dependent effect. Read more: ow.ly/jEjz50WaHfV #GlaucomaPhysician #GPnews #IOP #Conexiant

Flip through the pages of the digital edition at ow.ly/ByuV50W6yLp #GlaucomaPhysician #Gpnews #Coding #Conexiant

A recent study finds that informing patients of a glaucoma diagnosis may impact their mental well-being. Read more: ow.ly/PIJo50W91sH #GlaucomaPhysician #Gpnews #POAG #mentalhealth #Conexiant

Arsham Sheybani, MD, and Tugce Turer discuss how targeting uveoscleral outflow may result in greater IOP reduction with fewer complications. Read more: ow.ly/yUwE50W6yxy #GlaucomaPhysician #GPnews #Iantrek #iStarMedical #Conexiant

Editor in Chief Nathan M. Radcliffe, MD, reflects on the skills needed for success in the era of interventional glaucoma. Read more: ow.ly/LN5c50W6z4V #GlaucomaPhysician #GPnews #FromtheEditor #interventionalglaucoma #Conexiant

Perfuse Therapeutics reports positive data from a phase 2 clinical trial of PER-001 for glaucoma. Read more: ow.ly/Mp3C50Wfx02 #GlaucomaPhysician #GPnews #PerfuseTherapeutics #sustaineddrugdelivery #Conexiant

Kevin J. Corcoran explains how saving time on chart notes, while keeping a detailed medical record, is valuable and can improve practice revenue. Read more: ow.ly/V3Jh50W6yXf #GlaucomaPhysician #Gpnews #Coding #Conexiant